-+ 0.00%
-+ 0.00%
-+ 0.00%

SAGIMET BIOSCIENCES SHARES JUMP 52% PREMARKET AFTER ORAL ACNE DRUG WITH PARTNER ASCLETIS MET THE MAIN GOALS IN A LATE-STAGE TRIAL

Reuters·06/04/2025 09:15:55

Please log in to view news